Effect of Maternal Hyperglycemia on Fetal Pancreatic Islet Development

Area of Science:

• Developmental Biology
• Endocrinology
• Extracellular Matrix Research

Background:

• Fetal hyperglycemia disrupts organogenesis and adult organ function by altering extracellular matrix (ECM) synthesis and deposition.
• The role of the pancreatic ECM in pancreas development and the effects of hyperglycemia on it are not well understood.

Purpose of the Study:

• To investigate the impact of severe maternal hyperglycemia on ECM composition and endocrine pancreas development in E19.0 mouse fetuses.
• To analyze changes in specific ECM molecules, islet cell proliferation, alpha and beta cell distribution, and key gene expressions.

Main Methods:

• Immunostaining was used to evaluate deposition patterns of pan-laminin, laminin (alpha 1 and gamma 1 chains), and integrin alpha 3.
• Proliferative index of islet cells was assessed using PCNA immunostaining.
• Alpha and beta cell distribution were evaluated using glucagon and insulin immunostaining, respectively.
• RT-qPCR was employed to analyze Pdx1 and Pax4 gene expressions.

Main Results:

• Hyperglycemic fetuses showed weaker deposition of pan-laminin and laminin (alpha1, gamma1 chains) but increased integrin alpha 3 deposition in the peri-islet basement membrane.
• A lower proliferative index of endocrine cells was observed in the hyperglycemic group.
• The beta-cell area was increased, with a tendency towards lower Pdx1 and increased Pax4 expression in hyperglycemic fetuses.

Conclusions:

• Maternal hyperglycemia alters fetal endocrine pancreas morphogenesis.
• Changes in peri-islet basement membrane molecules, decreased endocrine cell proliferation, and altered gene expression (Pdx1, Pax4) are associated with hyperglycemia.
• These alterations may impact beta-cell differentiation and the overall proliferative state during fetal pancreatic development.